StonvexLoading…
StonvexStonvexStonvexCore line items from GSIT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 | Annual 2022 2022-03-31 |
|---|---|---|---|---|
Revenue | $20.52M | $21.77M | $29.69M | $33.38M |
Operating Income | $-10.84M | $-20.43M | $-15.81M | $-16.35M |
Net Income | $-10.64M | $-20.09M | $-15.98M | $-16.37M |
EPS (Diluted) | $-0.42 | $-0.80 | $-0.65 | $-0.67 |
Total Assets | $43.32M | $42.46M | $59.88M | $76.42M |
Total Liabilities | $15.09M | $6.49M | $8.50M | $11.97M |
Cash & Equivalents | $13.43M | $14.43M | $27.21M | $36.97M |
Free Cash Flow OCF − CapEx | $-13.02M | $-18.00M | $-17.16M | $-14.60M |
Shares Outstanding | 25.61M | 25.30M | 24.69M | 24.49M |